Patents by Inventor Marie-Francoise Yveline Coeffet-Le Gal

Marie-Francoise Yveline Coeffet-Le Gal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKER-BASED TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND DIABETIC KIDNEY DISEASE
    Publication number: 20240091303
    Abstract: Disclosed are compounds having structural formulas (I)-(XI), and related pharmaceutical compositions. Also disclosed are methods of selecting and treating human subjects suffering from a kidney disease, using the compounds of formulas (I)-(XI), and methods of determining the efficacy of TRPC5 inhibitor therapies using the same.
    Type: Application
    Filed: October 5, 2020
    Publication date: March 21, 2024
    Inventors: John Francis Reilly, Yossi Dagon, Hari Raghu, Marie-Francoise Yveline Coeffet-Le Gal, Matthew H. Daniels, Maolin Yu, Mark W. Ledeboer, Jean-Christophe P. Harmange, Peter H. Mundel
  • PYRIDAZINONES AND METHODS OF USE THEREOF
    Publication number: 20220152031
    Abstract: Disclosed are therapeutic methods, e.g., of treating kidney diseases, using compounds of Formula (A) in combination with a second therapeutic agent.
    Type: Application
    Filed: March 18, 2020
    Publication date: May 19, 2022
    Inventors: John Francis Reilly, Liron Walsh, Peter H. Mundel, Amy Kieu Duyen Westerling-Bui, Matthew H. Daniels, Maolin Yu, Mark W. Ledeboer, Jean-Christophe P. Harmange, Marie-Francoise Yveline Coeffet-Le Gal, Michael Broxson